Legend Biotech Corporation — Form 6-K Summary
Business Context and Reporting Period
Legend Biotech Corporation filed a Form 6-K dated September 24, 2026, reporting the results of its 2026 Annual General Meeting of Shareholders. The filing identifies the company as a foreign private issuer that files annual reports on Form 20-F.
Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial operating metrics.
Material Changes
The filing reports the occurrence of the 2026 Annual General Meeting and states that the voting results are included in Exhibit 99.1. The provided filing text does not include the detailed voting results or identify the specific shareholder resolutions considered.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual financial items are disclosed in the provided text.
The report, including Exhibit 99.1, is incorporated by reference into the company’s registration statements on Forms F-3 and S-8, to the extent not superseded by subsequently filed documents or reports.
Key Facts to Verify
- Review Exhibit 99.1 for the full voting results and outcomes of each shareholder proposal.
- Confirm whether any director elections, compensation matters, auditor appointments, or other resolutions were approved or rejected.
- Check subsequent SEC filings for additional disclosures or documents that supersede or supplement this Form 6-K.
- Note that the provided text contains no current-period financial results or quantitative guidance.